Biotech Investor Alex Karnal: GLP-1 Drugs Signal ‘Trillion-Dollar Revolution’ in Public Health
Source ↗
👁 0
💬 0
The post Biotech Investor Alex Karnal: GLP-1 Drugs Signal ‘Trillion-Dollar Revolution’ in Public Health appeared first on 24/7 Wall St..
Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech companies before declaring on the Invest Like the Best podcast that “2025 was probably the single most exciting year in my entire journey.” The catalyst: GLP-1 medicines. His claim deserves scrutiny because the inves
Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech companies before declaring on the Invest Like the Best podcast that “2025 was probably the single most exciting year in my entire journey.” The catalyst: GLP-1 medicines. His claim deserves scrutiny because the inves
Comments (0)